Search for the latest oncology news by tumour type
An analysis of data from the National Cancer Database found that after implementation of the…
An interim analysis of the international randomised, phase III ENZAMET trial found that 80% of…
A new blood test for women with breast cancer can predict how well patients will…
The randomised, phase III POLO trial found that maintenance therapy with the PARP inhibitor olaparib…
Nathan Bahary, University of Pittsburgh With Alex Trebek’s recent announcement that his pancreatic cancer is…
Crizotinib and entrectinib are both active against ROS1 non-small cell lung cancer. But which is…
Igor Puzanov, MD, Director of the Early Phase Clinical Trials Program and Chief of Melanoma…
Neoadjuvant, or pre-surgical, treatment with nivolumab plus ipilimumab resulted in an overall major pathologic response…
A precision medicine targeting a key protein which helps cancer cells to tolerate DNA damage…
The KEYNOTE-062 phase III randomised clinical trial achieved its primary endpoint, showing that for patients…